We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Molecular Diagnostics

Image Credit: Adobe Stock

Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

A new test that analyzes intact circulating tumor cells aims to offer a clinically superior alternative to standard fragment-based blood tests. More...
11 Aug 2026
Image: The platform analyzes cell-free DNA in blood, searching for minute amounts of tumor-derived fragments among background DNA (Image Credit: Adobe Stock)

Blood Test Could Help Fast-Track Lymphoma Diagnosis in Resource-Limited Settings

A blood-based AI platform triages suspected lymphoma for faster biopsy, offering strong detection and differentiation from benign causes. More...
10 Aug 2026
Image Credit: Adobe Stock

Liquid Biopsy Assay Enriches Tumor DNA for Early Detection and Monitoring

A new liquid biopsy method isolates over 99% pure ctDNA from plasma, enabling multi-cancer early detection and MRD surveillance. More...
10 Aug 2026
Image: The Co-Dx PCR platform combines real-time PCR quality with a lower-cost instrument and consumable model to facilitate deployment near the patient (Photo courtesy of Co-Diagnostics, Inc.)

Point-of-Care Multiplex PCR Test Submitted to FDA for Flu A/B and RSV Detection

Co-Diagnostics has submitted a Dual 510(k) with concurrent CLIA Waiver to the FDA for Flu A/B & RSV multiplex test. More...
10 Aug 2026
Image: The two new tests are used with the LightCycler 480 and LightCycler PRO instruments (Photo courtesy of Roche)

New PCR Assays Expand Cyclospora Testing for Outbreak Surveillance

New real-time PCR assays enable rapid Cyclospora detection and flexible multiplexing to scale lab capacity during outbreaks. More...
07 Aug 2026
Image: The dPCR assay targets the most common KMT2A partner fusion genes found in AML and ALL, aligning with the disease biology relevant to current menin inhibitor programs (Image Credit: Shutterstock)

Global Testing Service Advances Leukemia MRD Monitoring

A new digital PCR test measures residual disease markers in acute leukemias with high sensitivity. More...
05 Aug 2026
Image: Medicare coverage for NeXT Personal now spans four indications (Photo courtesy of Personalis)

Ultrasensitive MRD Assay Gains Medicare Coverage for Immunotherapy and Breast Cancer Monitoring

Personalis’ NeXT Personal received expanded Medicare coverage for immuno-oncology and neoadjuvant breast cancer monitoring. More...
05 Aug 2026
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Urine Analyzer
respons® UDS100
New
Platelet Function Analyzer
PL-12


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.